AMANDA BATTLES: Open Payments
NPI 1609576180 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $427 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 2 | $32 |
| Eisai Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Corium, LLC | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Verity Pharmaceuticals Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Wegovy, Ozempic, JARDIANCE, Leqembi, VOQUEZNA, Azstarys, NEXLETOL, TZIELD.
Industry payments across GA — which companies pay providers there.
